Medartis Holding AG
MDRSFOTCHealthcare● Active
$115.00
+$0.00(+0.00%)
Market Cap$1.4B
P/E Ratio—
52W High$115
52W Low$66.68
Medartis Holding AG (MDRSF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDRSF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.27B | $0.22B | $0.21B | $0.18B | $0.16B |
| Cost of Revenue | $0.06B | $0.05B | $0.04B | $0.05B | $0.04B |
| Gross Profit | $0.20B | $0.18B | $0.17B | $0.14B | $0.12B |
| Gross Margin %(computed) | 75.89% | 79.47% | 79.04% | 74.05% | 76.04% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.04B | $0.03B | $0.02B | $0.02B |
| G&A Expenses | $0.04B | $0.04B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.20B | $0.17B | $0.16B | $0.14B | $0.11B |
| Operating Income | $0.00B | $0.01B | $0.01B | ($0.00B) | $0.01B |
| Operating Margin %(computed) | 0.72% | 3.50% | 4.29% | -1.02% | 6.89% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.00B | $0.00B | ($0.01B) | $0.01B |
| Income Tax Expense | $0.00B | ($0.00B) | $0.00B | ($0.00B) | $0.00B |
| Net Income | $0.01B | $0.00B | $0.00B | ($0.01B) | $0.01B |
| Net Margin %(computed) | 3.10% | 1.57% | 0.29% | -3.16% | 4.28% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.67 | $0.26 | $0.05 | $-0.49 | $0.58 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.05B | $0.03B | $0.02B | $0.02B | $0.03B |
| EBITDA Margin %(computed) | 16.98% | 13.43% | 11.65% | 8.88% | 15.91% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CHF · B
Explore more Medartis Holding AG data
About Medartis Holding AG (MDRSF) Income Statement
Medartis Holding AG (MDRSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MDRSF reported revenue of $0.27B, gross profit of $0.20B (gross margin 75.89%), and net income of $0.01B — a net profit margin of 3.10%.
Frequently asked questions
MDRSF · 4 questionsMedartis Holding AG (MDRSF) reported revenue of $0.27B for 2025, up 19.8% year-over-year.
MDRSF revenueMDRSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08